These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 27852052)

  • 1. MicroRNAs for osteosarcoma in the mouse: a meta-analysis.
    Chang J; Yao M; Li Y; Zhao D; Hu S; Cui X; Liu G; Shi Q; Wang Y; Yang Y
    Oncotarget; 2016 Dec; 7(51):85650-85674. PubMed ID: 27852052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of microRNAs in osteosarcoma: A meta-analysis.
    Kim YH; Goh TS; Lee CS; Oh SO; Kim JI; Jeung SH; Pak K
    Oncotarget; 2017 Jan; 8(5):8726-8737. PubMed ID: 28060730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a novel miRNA-target gene regulatory network in osteosarcoma by integrating transcriptome analysis.
    He C; Gao H; Fan X; Wang M; Liu W; Huang W; Yang Y
    Int J Clin Exp Pathol; 2015; 8(7):8348-57. PubMed ID: 26339404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-suppressive microRNA-let-7a inhibits cell proliferation via targeting of E2F2 in osteosarcoma cells.
    Iwasaki T; Tanaka K; Kawano M; Itonaga I; Tsumura H
    Int J Oncol; 2015 Apr; 46(4):1543-50. PubMed ID: 25647078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of an integrated human osteosarcoma database, HOsDb, based on literature mining, microarray analysis, and database retrieval.
    Sun Y; Wang L; Li C; Gu R; Zang W; Song W; Xia P
    BMC Cancer; 2020 May; 20(1):390. PubMed ID: 32375685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum microRNA-221 functions as a potential diagnostic and prognostic marker for patients with osteosarcoma.
    Yang Z; Zhang Y; Zhang X; Zhang M; Liu H; Zhang S; Qi B; Sun X
    Biomed Pharmacother; 2015 Oct; 75():153-8. PubMed ID: 26422796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA profiling identifies deregulated miRNAs associated with osteosarcoma development and time to metastasis in two large cohorts.
    Andersen GB; Knudsen A; Hager H; Hansen LL; Tost J
    Mol Oncol; 2018 Jan; 12(1):114-131. PubMed ID: 29120535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness.
    Di Fiore R; Fanale D; Drago-Ferrante R; Chiaradonna F; Giuliano M; De Blasio A; Amodeo V; Corsini LR; Bazan V; Tesoriere G; Vento R; Russo A
    J Cell Physiol; 2013 Jun; 228(6):1189-201. PubMed ID: 23129384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-27a and miR-27a* contribute to metastatic properties of osteosarcoma cells.
    Salah Z; Arafeh R; Maximov V; Galasso M; Khawaled S; Abou-Sharieha S; Volinia S; Jones KB; Croce CM; Aqeilan RI
    Oncotarget; 2015 Mar; 6(7):4920-35. PubMed ID: 25749032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-species identification of a plasma microRNA signature for detection, therapeutic monitoring, and prognosis in osteosarcoma.
    Allen-Rhoades W; Kurenbekova L; Satterfield L; Parikh N; Fuja D; Shuck RL; Rainusso N; Trucco M; Barkauskas DA; Jo E; Ahern C; Hilsenbeck S; Donehower LA; Yustein JT
    Cancer Med; 2015 Jul; 4(7):977-88. PubMed ID: 25784290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA and Bone Cancer.
    Nugent M
    Adv Exp Med Biol; 2015; 889():201-30. PubMed ID: 26659003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement and Clinical Aspects of MicroRNA in Osteosarcoma.
    Ram Kumar RM; Boro A; Fuchs B
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27271607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-144 suppresses osteosarcoma growth and metastasis by targeting ROCK1 and ROCK2.
    Wang W; Zhou X; Wei M
    Oncotarget; 2015 Apr; 6(12):10297-308. PubMed ID: 25912304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Molecular Genetic Expression as a Novel Biomarker in the Evaluation and Monitoring of Patients With Osteosarcoma-Subtype Bone Cancer Disease.
    Hutanu D; Popescu R; Stefanescu H; Pirtea L; Candea A; Sarau C; Boruga O; Mehdi L; Ciuca I; Tanasescu S
    Biochem Genet; 2017 Aug; 55(4):291-299. PubMed ID: 28425009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of microRNA-210 inhibits osteosarcoma growth in vitro and in vivo.
    Liu C; Tang X
    Mol Med Rep; 2015 Sep; 12(3):3674-3680. PubMed ID: 26044868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNAs in osteosarcoma: from biological players to clinical contributors, a review.
    Zhou G; Shi X; Zhang J; Wu S; Zhao J
    J Int Med Res; 2013 Feb; 41(1):1-12. PubMed ID: 23569124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue microRNA-126 expression level predicts outcome in human osteosarcoma.
    Liu W; Zhao ZY; Shi L; Yuan WD
    Diagn Pathol; 2015 Jul; 10():116. PubMed ID: 26194657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel prognostic signature related to programmed cell death in osteosarcoma.
    Jiang YC; Xu QT; Wang HB; Ren SY; Zhang Y
    Front Immunol; 2024; 15():1427661. PubMed ID: 39015570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening candidate microRNA-mRNA network for predicting the response to chemoresistance in osteosarcoma by bioinformatics analysis.
    Dai P; He Y; Luo G; Deng J; Jiang N; Fang T; Li Y; Cheng Y
    J Cell Biochem; 2019 Oct; 120(10):16798-16810. PubMed ID: 31090103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mediator of RNA polymerase II transcription subunit 19 promotes osteosarcoma growth and metastasis and associates with prognosis.
    Yu W; Zhang Z; Min D; Yang Q; Du X; Tang L; Lin F; Sun Y; Zhao H; Zheng S; He A; Li H; Yao Y; Shen Z
    Eur J Cancer; 2014 Apr; 50(6):1125-36. PubMed ID: 24565852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.